Michel Pansiéri - Concepedia

Author

Michel Pansiéri

Inserm

Also Known As

Hugo Arbanil, M Pansieri, M. PANSIERI, M. Pansieri, MICHEL PANSIERI, Michel PANSIERI, Michel Pansieri, Michel Pansiéri

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Inserm Laboratoire Informatique d'Avignon Centre Hospitalier Universitaire Henri-Mondor Assistance Publique – Hôpitaux de Paris Centre Hospitalier Annecy Genevois

About

Michel Pansiéri is an author at Inserm specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	555
2	Public Health	6	6	331
3	Health Sciences	1	1	12
4	Cardiothoracic Surgery	1	1	31
5	Diabetes	1	1	61

Michel Pansiéri

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction Gilles Montalescot, Paul Barragan, Olivier Wittenberg, New England Journal of Medicine	2001	1.2K
High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes Laurent Bonello, Michel Pansiéri, Julien Mancini, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletCoronary Artery Disease	2011	208
Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel Laurent Bonello, Julien Mancini, Michel Pansiéri, Journal of Thrombosis and Haemostasis	2012	125
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial Johanne Silvain, Benoît Lattuca, Farzin Beygui, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineCardiovascular Pharmacology	2020	122
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement Sylvain Beurtheret, Nicole Karam, Noémie Resseguier, Journal of the American College of Cardiology	2019	109
Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome Marc Laine, Corinne Frère, Richard Toesca, Thrombosis and Haemostasis Diabetic PatientsPlatelet ReactivityPharmacotherapyCoronary Artery DiseaseAcute Myocardial Infarction	2013	61
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type Edoardo Camenzind, Eric Boersma, William Wijns, European Heart Journal	2014	49
Rate of Nuisance Bleedings and Impact on Compliance to Prasugrel in Acute Coronary Syndromes Sebastien Arméro, Laurent Bonello, Julie Berbis, The American Journal of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseCoronary Artery DiseaseNuisance Bleedings	2011	35
Radiation Doses to Patients in Interventional Coronary Procedures—Estimation of Updated National Reference Levels by Dose Audit Jean-Louis Georges, Loïc Belle, C. Étard, Radiation Protection Dosimetry Preventive CardiologyLogistic AnalysisCoronary Artery DiseaseAcute Myocardial InfarctionInterventional Coronary Procedures—estimation	2016	31
Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention Marc Laine, Richard Toesca, Julie Berbis, Thrombosis Research Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseBlood PlateletCoronary Artery Disease	2013	29

Page 1